Literature DB >> 7058150

[Copper pathology (author's transl)].

B Mallet, J Romette, J D Di Costanzo.   

Abstract

Copper is an essential dietary component, being the coenzyme of many enzymes with oxidase activity, e.g. ceruloplasmin, superoxide dismutase, monoamine oxidase, etc. The metabolism of copper is complex and imperfectly known. Active transport of copper through the intestinal epithelial cells involves metallothionein, a protein rich in sulfhydryl groups which also binds the copper in excess and probably prevents absorption in toxic amounts. In hepatocytes a metallothionein facilitates absorption by a similar mechanism and regulates copper distribution in the liver: incorporation in an apoceruloplasmin, storage and synthesis of copper-dependent enzymes. Metallothioneins and ceruloplasmin are essential to adequate copper homeostasis. Apart from genetic disorders, diseases involving copper usually result from hypercupraemia of varied origin. Wilson's disease and Menkes' disease, although clinically and pathogenetically different, are both marked by low ceruloplasmin and copper serum levels. The excessive liver retention of copper in Wilson's disease might be due to increased avidity of hepatic metallothioneins for copper and decreased biliary excretion through lysosomal dysfunction. Menkes' disease might be due to low avidity of intestinal and hepatic metallothioneins for copper. The basic biochemical defect responsible for these two hereditary conditions has not yet been fully elucidated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058150

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  2 in total

1.  Serum zinc and copper in hyperlipoproteinemia.

Authors:  G Uza; S Gabor; A Kovats; R Vlaicu; M Cucuianu
Journal:  Biol Trace Elem Res       Date:  1985-11       Impact factor: 3.738

2.  Serum zinc and copper in patients with atherosclerosis and thromboangiitis obliterans.

Authors:  G Uza; R Vlaicu
Journal:  Biol Trace Elem Res       Date:  1989-06       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.